Zobrazeno 1 - 10
of 243
pro vyhledávání: '"Seddon, JA"'
Autor:
Seddon JA, Shingadia D
Publikováno v:
Infection and Drug Resistance, Vol 2014, Iss default, Pp 153-165 (2014)
James A Seddon,1 Delane Shingadia21Department of Paediatric Infectious Diseases, Imperial College London, London, UK; 2Department of Paediatric Infectious Diseases, Great Ormond Street Hospital, London, UKAbstract: Our understanding of the tuberculos
Externí odkaz:
https://doaj.org/article/cc180ecc5b53485a8084a6845c8c9f02
Autor:
Gureva, T, Turkova, A, Yablokova, E, Smirnova, P, Sveshnikova, O, Zolotaya, O, Nikishova, E, Heldal, E, Hinderaker, S, Seddon, JA, Mariandyshev, A
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 26(2)
No Abstract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e69aabf52af4de10abc568b3fd9bb7d9
https://pubmed.ncbi.nlm.nih.gov/35505480
https://pubmed.ncbi.nlm.nih.gov/35505480
Tuberculous meningitis is the most severe form of tuberculosis and causes widespread mortality and morbidity. Understanding of the epidemiology and pathogenesis is incomplete, and the optimal diagnosis and treatment are poorly defined. To generate re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::3d7ce823ef65c0594ef1824bef992357
http://hdl.handle.net/10044/1/78704
http://hdl.handle.net/10044/1/78704
Publikováno v:
e1338
e1329
e1329
Background Tuberculosis is recognised as a major cause of morbidity and mortality in children, with most cases in children going undiagnosed and resulting in poor outcomes. Household contact management, which aims to identify children with active tub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d9250337903aed4c84340ea31ebf18de
https://eprints.whiterose.ac.uk/135188/3/PIIS2214109X18304017_1.pdf
https://eprints.whiterose.ac.uk/135188/3/PIIS2214109X18304017_1.pdf
Autor:
Harausz, E, Garcia-Prats, A, Law, S, Schaaf, H, Kredo, T, Seddon, JA, Menzies, R, Turkova, A, Achar, J, Amanullah, F, Barry, P, Becerra, M, Chan, E, Chiotan, D, Crossa, A, Drobac, P, Fairlie, L, Falzon, D, Flood, J, Gegia, M, Hicks, R, Isaakidis, P, Kadri, S, Kampmann, B, Madhi, S, Marais, E, Mariandyshev, A, Mednez-Echevarria, A, Moore, B, Ozere, I, Padayatchi, N, Rybak, N, Santiago-Garcia, B, Shah, S, Sharma, S, Shim, T, Skrahina, A, Soriano-Arandes, A, Van den Boom, M, Van der Werf, M, Williams, B, Yablokova, E, Yim, J, Furin, J, Hesseling, A
Background: An estimated 32,000 children develop multidrug-resistant tuberculosis (MDR-TB; Mycobacterium tuberculosis resistant to isoniazid and rifampin) each year. Little is known about the optimal treatment for these children. Methods and Findings
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::b9d8e8576b7b900db971c304d821b8b1
http://hdl.handle.net/10044/1/60226
http://hdl.handle.net/10044/1/60226
Autor:
Kampmann, B, Seddon, JA, Paton, J, Nademi, Z, Keane, D, Williams, B, Williams, A, Liebeschutz, S, Riddell, A, Bernatoniene, J, Patel, S, Martinez, N, McMaster, P, Basu-Roy, R, Welch, SB
Rationale and Objective In order to identify infected contacts of tuberculosis (TB) cases, the UK National Institute for Health and Care Excellence (NICE) recommended the addition of interferon-gamma release assays (IGRA) to the tuberculin skin test
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e274dc14810bdd598b61ac839a74d73e
https://doi.org/10.1164/rccm.201707-1487oc
https://doi.org/10.1164/rccm.201707-1487oc
Traditionally paediatric tuberculosis (TB) treatment trials have been limited to phase I/II studies evaluating the pharmacokinetics and safety of drugs in children, with assumptions about efficacy made by extrapolating data from adults. However, it i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::5887fac20419548a2680654544e6a49e
http://hdl.handle.net/10044/1/58076
http://hdl.handle.net/10044/1/58076
Background Tuberculosis (TB) remains a leading cause of death in children globally. It is recognized that human immunodeficiency virus (HIV) infection increases the risk of developing TB, but our understanding of the impact of HIV on risk of mortalit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::ee185cfbefb54bdad48b1ee99ec1ce5c
http://hdl.handle.net/10044/1/50072
http://hdl.handle.net/10044/1/50072
Publikováno v:
S39
S34
S34
Inclusion of newly licensed or repurposed drugs in regimens to treat children for multidrug-resistant-tuberculosis may lead to therapy that is shorter than traditional regimens and composed only of oral medications. As an all-oral regimen may be more
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::d654bf94b937426a6beb2fce3ea95aaa
http://hdl.handle.net/10044/1/58118
http://hdl.handle.net/10044/1/58118